The venture capital company Asabys Partners, a member of Catalonia.health, and AltamarCAM Partners, a global investment firm specialized in private markets, have reached an agreement to integrate Aliath Bioventures, a member of Catalonia.health, the life sciences team, into Asabys and to co-manage the Alta Life Sciences Spain I FCR fund.
The investment teams of both firms have been working together for several years on the boards of companies in which both managers have invested, such as Deepull, Ona, and Inbrain, also members of Catalonia.health, executing similar investment strategies. The integration will strengthen capabilities, generate synergies, and ensure continuity in value creation for investors.
As part of this agreement, the Alta Life Sciences Spain I FCR fund will be co-managed by both firms. Asabys’ founding partners, Clara Campàs and Josep Sanfeliu, will join the Fund’s Investment Committee, and the Aliath Bioventures team will integrate into Asabys; in particular, Montserrat Vendrell and José María Fernández will become partners at Asabys.
Josep Ll. Sanfeliu, Co-Founder and Managing Partner of Asabys, said: “The integration of Aliath represents a natural evolution in Asabys’ strategic path towards 2030, accelerating our growing capacity to invest and manage investments in healthcare innovation”.
Moreover, Clara Campàs, also Co-Founder and Managing Partner of the firm, added: “With Aliath/AltamarCAM, we share a similar investment philosophy, scientific rigor, and a long-term commitment to founders.”
Comments